Ford Hutman Media provides media relations, thought leadership and executive visibility to life science companies. Clients range from venture-backed startups to large cap public companies. The firm was founded by Rachel Ford Hutman, a media relations standout and global health industry connector. Rachel started her career as a reporter and excels at working with the media to bring health stories to life while still making them accessible to stakeholders. The firm works with a network of creative and technology partners to extend its core offering based on client needs.

Rachel has worked on some of the world's biggest therapies and medical technologies of all time, including the first RNAi therapy (Alnylam’s ONPATTRO), the first therapy for DMD (Sarepta’s EXONDYS 51), the first technology in the world to personalize insulin 24 hrs. a day (Medtronic’s MiniMed 670G), IBM's AI launch into healthcare (Watson Health) and Google's sister life science company (Verily). She has counseled some of the most well-known health/ technology organizations and developed communications strategies for the world's biggest brands (Verily, Johnson & Johnson, Medtronic, Pfizer, IBM, Best Buy, Takeda, Sanofi, Shire, Brigham & Women’s, NHS), but she is most proud of her work telling patient stories.